Fortrea Corp (FTRE) - Gross Profit Ratio

Official company branding of Fortrea Clinical (FTRE)

Fortrea Holdings Inc. generates revenue from complex clinical trials within an oligopoly characterized by high barriers to entry. Gross margin fluctuations demonstrate current efficiency, with the latest figure standing at 17.00. Risks are linked to potential budget cuts by clients. Management is currently focusing on optimizing internal processes and increasing profitability following the business spin-off.

FTRE (Fortrea Corp) Gross Margin history from 02/21/2024 to 11/20/2026

Comprehensive metric breakdowns and analytics for Fortrea Holdings Inc. (FTRE)

- stock price and consensus target price:
- cash balance and cash flow data:
Fundamental valuation:Fortrea Holdings Inc (FTRE)
Manufactured product of Fortrea Clinical

Gross margin measures the portion of revenue remaining after covering direct operating costs, allowing for an assessment of the fundamental efficiency of service production. By analyzing the gross margin rate, an investor can see the balance between AI-driven data automation and inevitable personnel costs in hospitals, which determines the real profitability of the Fortrea Holdings Inc. (FTRE) business model.